Gabrielle van Ramshorst, MD FECSM FEBS FSSO Profile
Gabrielle van Ramshorst, MD FECSM FEBS FSSO

@GabrielleVanRam

Followers
2K
Following
9K
Media
236
Statuses
2K

Surgical oncologist, Ass Editor Colorectal Disease, Editorial Board IGJC, ENYGO & SSO, ESCP enthusiast, influencer, polyglot, mother (2), Associate Professor

Ghent, OH
Joined September 2018
Don't wanna be here? Send us removal request.
@littlemissileo
SueB
26 days
Are the @eurohernias and @AmericanHernia guidelines on abdominal closure relevant for #Colorectal or #EmergencySurgery patients? Read our analysis just published in @Hernia_official and find out! Thanks for having me as part of this great team @GabrielleVanRam @drfrancescopata
@drfrancescopata
Francesco Pata
26 days
Just published in @Hernia_official this trie group effort of @escp_tweets in analysing supporting evidence about colorectal and emergency patients in #EHS and @AmericanHernia guidelines. Collaboration is the key! https://t.co/MgsGppKsJP #colorectalsurgery #colorectalreseach
0
8
14
@drfrancescopata
Francesco Pata
26 days
Just published in @Hernia_official this trie group effort of @escp_tweets in analysing supporting evidence about colorectal and emergency patients in #EHS and @AmericanHernia guidelines. Collaboration is the key! https://t.co/MgsGppKsJP #colorectalsurgery #colorectalreseach
0
4
7
@SocSurgOnc
Society of Surgical Oncology
1 month
The SSO was honored to attend the 44th ESSO Congress in Gothenburg, Sweden, and to engage with the esteemed leadership of @ESSOnews. We are proud to continue fostering international collaboration and innovation in surgical oncology through global engagement. #ESSO44
0
7
21
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
Quentin Denost on core criteria for Centers of Excellence for Rectal Cancer, reflecting on data from France. Not just volume, you need the right team to support the patient throughout the cancer journey #ESSO44 @ESSOnews @OncoAlert
0
8
16
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
How much harm can AI do to patients? @pedrogouveia vs. Tibor Kovacs in the Debate on AI use in breast cancer #ESSO44 @ESSOnews @OncoAlert
0
5
9
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
To excise or not to excise DCIS, that's the question.... Lynda Wyld vs. Marie-Jeanne Vrancken Peeters in F4-5 #ESSO44 @ESSOnews @OncoAlert
0
4
10
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
"Most distant (rectal cancer) metastases originate from the original tumour, but it would be a stupid local regrowth tumour if it was sitting in the rectum for a year and did not metastasize..." according to @ESSOnews President Geerard Beets #ESSO44 @OncoAlert
2
6
12
@OncoAlert
OncoAlert
1 month
The Future of Surgical Oncology looks Very Bright, Dynamic and Fun The Young Surgical Oncologists at #ESSO44 🇸🇪 in Gothenburg @BexeLindskog @jzager99 @moffittnews @LauraLorenzonMD @WimCeelen @Surgeonjakob @itrisabel @SOS_Pk @hjmajid @martajimenez135 @OlofssonBagge
0
9
18
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
TNT for rectal cancer: are we providing too many options? @3isac asks... Patient input is needed for defining treatment goals of TNT: cCR? OS? QOL? TME-free survival? #ESSO44 @ESSOnews @OncoAlert
1
8
16
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
Quantifying ICG? Strategies for perfusion assessment as explained by Sven Mieog #ESSO44 @ESSOnews @OncoAlert
0
6
12
@OncoAlert
OncoAlert
1 month
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Isabel Rubio De-Escalate Staging and Management of the Axilla Recurrent Breast Cancer Isolated axillary recurrence after prior #BreastCancer treatment presents a complex management challenge, balancing oncologic
0
11
21
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
Mr. Bach vs. Mrs. Harji debating local excision of rectal cancer after a good response to neoadjuvant therapy: "Genius!" or "Nope, Thank You"? Planned vs. unplanned local excision, ugly vs. not-that-ugly tumour before neoadjuvant therapy matter! #ESSO44 @ESSOnews @OncoAlert
0
5
9
@OncoAlert
OncoAlert
1 month
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Philipp Lennartsson 🇸🇪 Best Swedish Abstracts: The Role of Tumor Location in Pancreatic Cancer on Perioperative Outcome and Long-Term Survival Analysis of survival in patients with resected pancreatic cancer from the
0
13
19
@OncoAlert
OncoAlert
1 month
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Localisation and Resection of #Melanoma Metastases This presentation addresses strategies for detecting metastatic disease following neoadjuvant therapy and emphasize
0
13
19
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
Note the final challenge!
1
0
1
@GabrielleVanRam
Gabrielle van Ramshorst, MD FECSM FEBS FSSO
1 month
Prof. Beata Rau was awarded with the ESSO Medal for her outstanding contributions to the field of Surgical Oncology, and is now presenting 'Women's path through Surgical Oncology" in F4-5 #ESSO44 @ESSOnews @OncoAlert #WomenInSurgery
1
7
16
@OncoAlert
OncoAlert
1 month
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪 dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy? In oesophageal and gastric cancer, tumours with defect mismatched repair genes (dMMR) are in minority but
0
13
18